Wordt geladen...

Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer

BACKGROUND: HER2/neu overexpression is linked to promotion of angiogenesis in breast cancer. We therefore tested the activity of the combination of Trastuzumab with metronomic, low dose chemotherapy with cyclophosphamide (CTX) and methotrexate (MTX) in metastatic breast cancer (MBC). METHODS: Betwee...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Orlando, Laura, Cardillo, Anna, Ghisini, Raffaella, Rocca, Andrea, Balduzzi, Alessandra, Torrisi, Rosalba, Peruzzotti, Giulia, Goldhirsch, Aron, Pietri, Elisabetta, Colleoni, Marco
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2006
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1579231/
https://ncbi.nlm.nih.gov/pubmed/16978400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-6-225
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!